Description
Description
ITPP Myo-Inositol
Myo-inositol trispyrophosphate (ITPP) is a novel allosteric effector (alteration of the enzyme) of hemoglobin with high permeation selectivity across the red blood cell plasma membrane. Due to its potential to reduce the oxygen affinity of hemoglobin, ITPP application results in an enhanced oxygen release in hypoxic tissues. It is currently being investigated in hopes of aiding patients weakened by myocardial infarctions due to its ability to increase oxygen supply to weakened or damaged cardiac muscle.
ITPP | |
CAS Number | 623552-11-4 |
Molar Mass | 605.984 g·mol−1 |
Chemical Formula | C6H12O21P6 |
IUPAC Name | 4,6,11,13,18,20-hexahydroxy-3,5,7,10,12,14,17,19,21-nonaoxa-4λ5,6λ5,11λ5,13λ5,18λ5,20λ5-hexaphosphatetracyclo[14.5.0.02,8.09,15]henicosane 4,6,11,13,18,20-hexaoxide |
Additional information
Additional information
Dose | 30ml/33mg per ml/1000mg |
---|
Abraham Mcdaniel –
Remarkable support for overall well-being.
Tiago White –
Exceptional quality and effectiveness
Dean Cannon –
Super easy to dose and the results definitely exceeded my expectations. Definitely worth a try.
Peter Arroyo –
Provides a powerful energy boost